News

The patents represent the first issued for a family of applications focused in brachytherapy, said Cianna. According to the company, the Savi multi-catheter open architecture design allows for

This transfection device simplifies the delivery of DNA, RNA, and proteins into a wide range of mammalian cell types, especially difficult to transfect cells, such as many types

According to FluGen, the easy-to-use, disposable micro-device, roughly the size of a poker chip, painlessly delivers seasonal and pandemic influenza vaccines. The vaccine-delivery technology also may improve vaccination

VIAject is Biodel’s investigational ultra-rapid-acting injectable human insulin intended for meal-time use by people with type 1 and type 2 diabetes. The new drug application (NDA) will be

The sulfacetamide sodium topical suspension, 10% (lotion) has been determined to be therapeutically equivalent to Sanofi-Aventis’s Klaron lotion, 10%, which is indicated for the topical treatment of acne.

The Archexin Phase IIa trial is a single-arm, open-label study conducted at global sites in the US and India. Archexin will be administered in combination with gemcitabine in

Under the terms of the agreement, Aveo will receive an up-front payment and is eligible to receive milestone payments based upon the achievement of specified development goals. Biogen

Novartis has received a positive opinion supporting EU approval of Glivec as a post-surgery treatment for patients at significant risk of relapse following removal of gastrointestinal stromal tumors.

Ms Leonard said: “After having achieved my goal of successfully identifying and acquiring a FDA cleared, CLIA waived product that offers CLX the opportunity to become market leader